These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 309191

  • 1. Platelet-binding of the von Willebrand factor.
    Green D, Muller HP.
    Thromb Haemost; 1978 Jun 30; 39(3):689-94. PubMed ID: 309191
    [Abstract] [Full Text] [Related]

  • 2. Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination.
    Moake JL, Olson JD, Troll JH, Weinger RS, Peterson DM, Cimo PL.
    J Lab Clin Med; 1980 Jul 30; 96(1):168-84. PubMed ID: 6967100
    [Abstract] [Full Text] [Related]

  • 3. Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.
    Kao KJ, Pizzo SV, McKee PA.
    J Clin Invest; 1979 Apr 30; 63(4):656-64. PubMed ID: 108291
    [Abstract] [Full Text] [Related]

  • 4. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
    Grainick HR, Williams SB, Coller BS.
    J Clin Invest; 1985 Jan 30; 75(1):19-25. PubMed ID: 2981249
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Binding of factor VIII/Willebrand to Bernard-Soulier and thrombasthenic platelets (author's transl)].
    Ruan C, Tobelem G, Caen JP.
    Nouv Rev Fr Hematol (1978); 1981 Jan 30; 23(2):89-93. PubMed ID: 6794004
    [Abstract] [Full Text] [Related]

  • 7. Effect of carbohydrate modifications of factor VIII/von Willebrand factor on binding to platelets.
    Goudemand J, Mazurier C, Samor B, Bouquelet S, Montreuil J, Goudemand M.
    Thromb Haemost; 1985 Jun 24; 53(3):390-5. PubMed ID: 2864750
    [Abstract] [Full Text] [Related]

  • 8. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
    Tout H, Obert B, Houllier A, Fressinaud E, Rothschild C, Meyer D, Girma JP.
    Thromb Haemost; 2000 Feb 24; 83(2):274-81. PubMed ID: 10739386
    [Abstract] [Full Text] [Related]

  • 9. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
    Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D.
    Thromb Haemost; 1990 Oct 22; 64(2):326-32. PubMed ID: 1702906
    [Abstract] [Full Text] [Related]

  • 10. The physical exchange of factor VIII (FVIII) between von Willebrand factor and activated platelets and the effect of the FVIII B-domain on platelet binding.
    Li X, Gabriel DA.
    Biochemistry; 1997 Sep 02; 36(35):10760-7. PubMed ID: 9271507
    [Abstract] [Full Text] [Related]

  • 11. Immunoinhibition of ristocetin-induced platelet aggregation.
    Nachman RL, Jaffe EA, Weksler BB.
    J Clin Invest; 1977 Jan 02; 59(1):143-8. PubMed ID: 299747
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of factor VIII-von Willebrand factor ristocetin cofactor activity by monoclonal antibodies.
    Hornsey V, Micklem LR, McCann MC, James K, Dawes J, McClelland DB, Prowse CV.
    Thromb Haemost; 1985 Aug 30; 54(2):510-4. PubMed ID: 3878608
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR, Williams SB, McKeown LP, Rick ME, Maisonneuve P, Jenneau C, Sultan Y.
    J Clin Invest; 1985 Oct 30; 76(4):1522-9. PubMed ID: 2932469
    [Abstract] [Full Text] [Related]

  • 16. Binding of factor VIII-von Willebrand factor to human arterial subendothelium precedes increased platelet adhesion and enhances platelet spreading.
    Bolhuis PA, Sakariassen KS, Sander HJ, Bouma BN, Sixma JJ.
    J Lab Clin Med; 1981 Apr 30; 97(4):568-76. PubMed ID: 6782184
    [Abstract] [Full Text] [Related]

  • 17. Proceedings: Interaction of ristocetin (R), von Willebrand factor (vWF), factor VIII clotting activity (VIIIc) and platelets.
    Zucker MB, McPherson J, Kim SJ, Macdonald VE, Taylor D, Johnson AJ, Barlow GH.
    Thromb Diath Haemorrh; 1975 Nov 15; 34(2):582. PubMed ID: 1081748
    [No Abstract] [Full Text] [Related]

  • 18. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
    Takahashi H, Shibata A.
    Thromb Haemost; 1984 Dec 29; 52(3):267-70. PubMed ID: 6241752
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
    Zucker MB, Puszkin EG, Sussman II, Mauss EA.
    J Lab Clin Med; 1990 Sep 29; 116(3):305-14. PubMed ID: 2401846
    [Abstract] [Full Text] [Related]

  • 20. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
    Tornai I, Arnout J, Deckmyn H, Peerlinck K, Vermylen J.
    J Clin Invest; 1993 Jan 29; 91(1):273-82. PubMed ID: 8423224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.